USP <797> Environmental Monitoring: When and How to Use a Contract Testing Lab

Environmental monitoring is a system, not a monthly chore

USP <797> frames sterile compounding as a controlled process. Environmental monitoring (EM) is how you prove the environment remains under control—not a paperwork ritual performed only before inspections.

Whether you are a 503A compounding pharmacy or supporting sterile operations at larger scale, EM data only helps if it is:

• Collected with a defined plan
• Handled with chain-of-custody discipline
• Incubated and read with competent microbiology
• Trended over time
• Linked to investigations and CAPA when action levels are exceeded

Many pharmacies perform sampling in-house and outsource incubation, enumeration, and identification. Others outsource the full viable monitoring package. Both models can work. The failure mode is mixing models without clear ownership.

What “good” EM looks like in plain language

A defensible program usually includes:

Nonviable particle monitoring

Periodic or continuous particle counting in classified areas, with certification and routine verification practices appropriate to your facility design.

Viable air monitoring

Active air sampling (volumetric) and/or settle plates according to your SOPs and risk assessment, in locations that reflect actual operations—not only the easiest corner of the room.

Surface monitoring

Contact plates or swabs on work surfaces, equipment, and other sites justified by process risk.

Personnel monitoring

Glove fingertip and other personnel sampling tied to aseptic behavior and media fill strategy.

Trending and response

Alert/action concepts, documented responses, organism identification when indicated, and management review.

USP expectations evolve with revisions; always align SOPs to the currently applicable chapter text and your state board expectations. This article focuses on how to work with contract labs, not on replacing your pharmacist-in-charge judgment.

Why pharmacies outsource pieces of EM

Common reasons:

1. Incubator capacity and weekend coverage
2. Organism identification expertise (especially for action-level recoveries)
3. Independent read for high-stakes investigations
4. Staffing reality — technicians can sample; a CTL can specialize in read/ID
5. Surge support after construction, HVAC interventions, or adverse trends

Outsourcing does not outsource responsibility. Your facility still owns the program design, sampling execution quality, and CAPA decisions.

Decide what you are buying from the lab

Be explicit in vendor qualification:

Work package	Pharmacy typically owns	Lab typically owns
Sample plan design	Yes	Consultative input only
Sampling execution	Usually yes	Sometimes (mobile teams—rare for pharmacies)
Plate supply	Either	Either
Incubation & enumeration	Optional outsource	Core CTL service
Genus/species ID	Optional outsource	Core CTL differentiator
Trending software	Pharmacy QMS	Rarely
Investigation narrative	Pharmacy lead	Lab contributes analytical facts

If a quote only says “EM testing – $X/plate,” ask what is included: media type, incubation scheme, enumeration, ID method (MALDI, sequencing, biochemical), and turnaround for ID.

Sampling quality beats laboratory brilliance

The best ISO 17025 lab cannot rescue poor sampling technique.

Before blaming the CTL for “weird results,” audit:

• Aseptic plate handling and expiration dating
• Sampler calibration and flow verification for active air devices
• Contact plate pressure/time consistency
• Transport time and temperature
• Label integrity (location codes that match your map)
• Whether samples sat in a car for hours

Put transport requirements in the quality agreement. Strong labs refuse compromised samples instead of quietly incubating them.

Identification: the hidden cost (and value)

When action levels are exceeded, identification quality drives the investigation:

• Skin flora vs water organism vs mold tells different stories
• Speciation can distinguish colonization patterns from a true process breach
• Recurring organisms may implicate a specific room, gowning practice, or material

Ask labs:

• What ID methods are in scope?
• When do they escalate from Gram stain / colony morphology to definitive ID?
• How are mixed cultures handled?
• What is the ID TAT after enumeration?

For mold recoveries, confirm mycological expertise—not every food-micro lab is a pharmaceutical EM partner.

Building an EM quality agreement that auditors respect

Include:

• Approved sample types and media
• Incubation temperatures/times (or reference to lab SOP IDs)
• Notification triggers (action-level recoveries, invalid tests, temperature excursions)
• Data integrity / record retention expectations
• On-call contacts for urgent recoveries
• Change control for method or site changes at the lab

Review the agreement annually or after major facility changes.

Trending: do not let PDFs become a graveyard

Contract labs often deliver excellent plate-level reports. Pharmacies still need:

• Location-based charts over months
• Separate personnel vs area trends
• Correlation with production volume, construction, and seasonality
• Clear thresholds for escalation to management

If your CTL offers a portal, great—verify exports for your QMS. If not, assign an owner to transpose critical results weekly. Untrended EM is delayed failure detection.

How to choose an EM-capable contract lab

Prioritize:

1. Pharmaceutical / compounding-relevant microbiology experience (not only food or clinical)
2. Transparent ISO/IEC 17025 scope for the tests you need
3. Reliable accessioning for plated media
4. Fast, clear communication on action-level recoveries
5. ID capabilities matched to your risk profile
6. Geographic logistics that protect sample integrity

Use LabCompare Rx to find labs with microbiology capabilities and request quotes that specify your EM package—not a generic “micro testing” line item.

Practical starter workflow for pharmacies new to outsourcing EM

1. Map your current sampling schedule and pain points (weekends, ID delays, backlog)
2. Decide which steps to outsource first (often incubation + ID)
3. Qualify 2 labs with a pilot month in one room or one sample type
4. Compare report clarity and notification speed—not only price per plate
5. Update SOPs and training so staff know the new chain of custody
6. Reassess after 90 days of trending

Bottom line

USP <797> EM is how sterile compounding proves control. Contract labs can strengthen incubation, enumeration, and identification—but only if your sampling discipline and quality agreement are equally strong. Treat EM vendors as extensions of your quality system, not as commodity plate readers.

When you are ready, compare pharmaceutical microbiology labs on LabCompare Rx and attach your EM package definition to every quote request.